Trade PCVX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vaxcyte, Inc. (PCVX) is trading at US$65.68, up 8.01% today as of Nov 4, 16:00 EST. The company has a market capitalisation of US$9.32B. Over the past 52 weeks, PCVX has traded between US$40.14 and US$90.75. On Syfe you can trade PCVX with $0 commission and add it to your watchlist.
| Previous close | US$60.81 |
|---|---|
| Market cap | US$9.32B |
| 52-week range | US$40.14 – US$90.75 |
| Volume | 2.24M |
| Exchange | US |
Vaxcyte, Inc.
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Year: 2020
Vaxcyte, Inc. (PCVX) stock is trading at US$65.68, +8.01% from the previous close of US$60.81.
The market cap for Vaxcyte, Inc. (PCVX) stock is approximately US$9.32B.
The 52-week high for Vaxcyte, Inc. (PCVX) stock is US$90.75.
The 52-week low for Vaxcyte, Inc. (PCVX) stock is US$40.14.
Vaxcyte, Inc. (PCVX) does not currently pay a dividend.
Stay on top of PCVX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
